Stocks and Investing Stocks and Investing
Mon, September 30, 2024
Fri, September 27, 2024
Thu, September 26, 2024
Wed, September 25, 2024

Leland Gershell Maintained (CAPR) at Buy with Increased Target to $43 on, Sep 25th, 2024


Published on 2024-10-28 14:27:20 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Maintained "Capricor Therapeutics, Inc." (CAPR) at Buy with Increased Target from $15 to $43 on, Sep 25th, 2024.

Leland has made no other calls on CAPR in the last 4 months.



There are 2 other peers that have a rating on CAPR. Out of the 2 peers that are also analyzing CAPR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Leland


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, September 24th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Friday, September 20th, 2024